- £57.13bn
- £69.64bn
- £31.38bn
- 65
- 45
- 70
- 66
Annual cashflow statement for GSK, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6,388 | 5,096 | 4,921 | 5,308 | 2,951 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -332 | 1,252 | 2,433 | 1,992 | 1,504 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 34 | -773 | -2,098 | -2,826 | -452 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 8,441 | 7,952 | 7,403 | 6,768 | 6,554 |
| Capital Expenditures | -2,239 | -2,931 | -2,258 | -2,344 | -2,982 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 4,400 | 1,154 | -6,514 | 749 | 1,753 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 2,161 | -1,777 | -8,772 | -1,595 | -1,229 |
| Financing Cash Flow Items | -1,950 | -1,401 | 9,089 | -837 | -910 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -10,132 | -7,589 | 823 | -5,641 | -4,726 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 431 | -1,443 | -394 | -567 | 545 |